Patents by Inventor Daniel H. Geschwind

Daniel H. Geschwind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES
    Publication number: 20240174625
    Abstract: Disclosed are compounds and methods for treating tauopathy.
    Type: Application
    Filed: February 18, 2022
    Publication date: May 30, 2024
    Inventors: Daniel H. Geschwind, Michael E. Jung, Liting Deng, Flora Hinz, Jennifer M. Murphy, Gaoyuan Ma, Robert Damoiseaux
  • GENES DYSREGULATED IN AUTISM AS BIOMARKERS AND TARGETS FOR THERAPEUTIC PATHWAYS
    Publication number: 20140194310
    Abstract: The disclosed invention comprises methods and materials for screening cells for genetic profiles associated with autism spectrum disorders. The methods typically involve isolating a cell from an individual and then observing the expression profile of one or more genes in the cell, wherein certain expression patterns of the genes observed are associated with autism spectrum disorders.
    Type: Application
    Filed: May 24, 2012
    Publication date: July 10, 2014
    Inventors: Daniel H. Geschwind, Irina Voineagu
  • PERIPHERAL GENE EXPRESSION BIOMARKERS FOR AUTISM
    Publication number: 20130210650
    Abstract: The disclosed invention comprises methods and materials for screening cells for genetic profiles associated with autism spectrum disorders. The methods typically involve isolating a cell from an individual and then observing the expression profile of one or more genes in the cell, wherein certain expression patterns of the genes observed are associated with autism spectrum disorders.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 15, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Daniel H. Geschwind, Yuhei Nishimura
  • Peripheral gene expression biomarkers for autism
    Patent number: 8173369
    Abstract: The disclosed invention comprises methods and materials for screening cells for genetic profiles associated with autism spectrum disorders. The methods typically involve isolating a cell from an individual and then observing the expression profile of one or more genes in the cell, wherein certain expression patterns of the genes observed are associated with autism spectrum disorders.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: May 8, 2012
    Assignee: The Regents of the University of California
    Inventors: Daniel H. Geschwind, Yuhei Nishimura
  • GENETIC RISK FACTOR FOR NEURODEGENERATIVE DISEASE
    Publication number: 20100267020
    Abstract: The present invention relates to single base polymorphisms in the glycogen synthase kinase 3 beta and risk for developing neurodegenerative disease.
    Type: Application
    Filed: February 2, 2009
    Publication date: October 21, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: DANIEL H. GESCHWIND, BARBARA A.J. SCHAFFER
  • PERIPHERAL GENE EXPRESSION BIOMARKERS FOR AUTISM
    Publication number: 20100125042
    Abstract: The disclosed invention comprises methods and materials for screening cells for genetic profiles associated with autism spectrum disorders. The methods typically involve isolating a cell from an individual and then observing the expression profile of one or more genes in the cell, wherein certain expression patterns of the genes observed are associated with autism spectrum disorders.
    Type: Application
    Filed: May 15, 2009
    Publication date: May 20, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Daniel H. Geschwind, Yuhei Nishimura
  • COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING BRAIN CANCER AND IDENTIFYING NEURAL STEM CELLS
    Publication number: 20090163406
    Abstract: In one aspect, the invention provides composition and methods for the diagnosis, prognosis and treatment of tumors and cancers, e.g., brain cancers. In one aspect, the invention provides compositions and methods for inhibiting the growth, proliferation, differentiation and/or survival of a neural stem cell or a cancer cell, or progenitor stem cell thereof. In one aspect, the invention provides compositions and methods for identifying the genetic profile of a brain cancer cell or a self-renewing neural cancer stem cell. In one aspect, the invention provides methods employing these profiles to identify compounds that inhibit tumor growth.
    Type: Application
    Filed: September 30, 2005
    Publication date: June 25, 2009
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Harley I. Kornblum, Daniel H. Geschwind, Ichiro Nakano, Joseph D. Dougherty, Jorge Lazareff, Paul S. Mischel, Michael D. Masterman Smith, Jing Huan, Houman D. Hemmati